{u'keywords': [u'individual needles', u'specification', u'ac patent', u'claims', u'crystalline form', u'perindopril tert-butylamine salt', u'apotex', u'Servier', u'claim', u'invention', u'new claims', u'reasonably clear disclosure', u'efficient filtration', u'Mr Hamer', u'amendments', u'amendment', u'Alpha Crystalline Patent', u'RGC Mineral Sands', u'court', u'homogeneous distribution', u'X-ray diffraction diagram', u'complete specification', u'process', u'skilled addressee', u'fair basis', u'Dr Kennedy', u'filterable individual needles', u'High Court', u'AC Patent application', u'body', u'perindopril salt', u'specification states', u'patent specification', u'best method', u'pharmaceutical composition', u'AC Patent specification', u'Wimmera Industrial Minerals', u'pharmaceutical compositions', u'Industrial Minerals Pty', u'Individual needles  Apotex', u'Patent  The specification', u'Les Laboratoires Servier', u'substance', u'matter', u'AC Patent  Servier', u'compound', u'oral administration', u'evidence', u'new claim', u'individual needle claims'], u'casename': u'Apotex Pty Ltd v Les Laboratoires Servier (No 2) [2009] FCA 1019 (11 September 2009)', u'filename': u'training_data/09_1019.xml'}